In addition to CTLA-4-CD28 fusion genes and CD28 gain/amplification [2, 28], a recent study shows that CD28 mutations were present in PTCL-TBX21 subtype (5.3%) and AITL (11.3%) [13]. This evidence concerns the gene CTLA4 and angioimmunoblastic T-cell lymphoma.